Clinical profile of primary sclerosing cholangitis in Singapore

Journal of Gastroenterology and Hepatology (Australia)

Volumn 17, Issue 8, 2002, Pages 908-913

  Ang, Tiing Leong ^a   Fock, Kwong Ming ^a   Ng, Tay Meng ^a   Teo, Eng Kiong ^a   Chua, Tju Siang ^a   Tan, Jessica Yi Lyn ^a  

^a CHANGI GENERAL HOSPITAL   (Singapore)

Author keywords

Epidemiology; Inflammatory bowel disease; pANCA; Primary sclerosing cholangitis

Indexed keywords

NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COMMON BILE DUCT DISEASE; CONTROLLED STUDY; DEATH; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE COURSE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENTERITIS; FEMALE; FOLLOW UP; HEPATIC DUCT; HUMAN; HUMAN TISSUE; LIVER ABSCESS; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FAILURE; LIVER FUNCTION TEST; MALE; OBSTRUCTIVE JAUNDICE; PREVALENCE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RECURRENT DISEASE; SEPSIS; SEX RATIO;

EID: 0036381030     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2002.02835.x     Document Type: Article

References (30)

1. Delbet MP. Retrecissement du choledoque. Cholecystoduodenostomie. Bull. Memoires Soc. Chirurg. Paris 1924; 50: 1144-6.
2. Schwartz SI, Dale WA. Primary sclerosing cholangitis: Review and report of six cases. Arch. Surg. 1958; 77: 439-51.
3. MacCarty RI, LaRusso NF, Wiesner RH, Ludwig J. Primary sclerosing cholangitis: Findings on cholangiography and pancreatography. Radiology 1983; 149: 39-44.
4. Boberg KM, Aadland E, Jahnsen J et al. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis and autoimmune hepatitis in a Norwegian population. Scand. J. Gastroenterol. 1998; 33: 99-103.
5. Lee YM, Kaplan MM. Primary sclerosing cholangitis. N. Engl. J. Med. 1995; 332: 924-33.
6. Kochhar R, Goenka MK, Das K et al. Primary sclerosing cholangitis: An experience from India. J. Gastroenterol. Hepatol. 1996; 11: 429-33.
7. Takikawa H, Manabe T. Primary sclerosing cholangitis in Japan: Analysis of 192 cases. J. Gastroenterol. 1997; 32: 134-7.
8. Chapman RWG, Arborgh BAM, Rhodes JM et al. Primary sclerosing cholangitis: A review of its clinical features, cholangiography, and hepatic histology. Gut 1980; 21: 870-7.
9. Wiesner RH, LaRusso NF. Clinicopathological features of the syndrome of primary sclerosing cholangitis. Gastroenterology 1980; 79: 200-6.
10. Aadland E, Schrumpf E, Fausa O et al. Primary sclerosing cholangitis: A long-term follow-up study. Scand. J. Gastroenterol. 1987; 22: 655-64.
11. Chong RSE, Ng HS, Teh LB, Ong YY, Ho MS. Primary sclerosing cholangitis: A report of 2 cases. Singapore Med. J. 1989; 30: 574-7.
12. Boberg KM, Mitchell S, Broome U et al. Natural history of primary sclerosing cholangitis. A long term follow-up study of 394 European primary sclerosing cholangitis patients. J. Hepatol. 2000; 34 (Suppl. 2): 32A.
13. Wiesner RH, Grambsch PM, Dickson ER et al. Primary sclerosing cholangitis: Natural history, prognostic factors and survival analysis. Hepatology 1989; 10: 430-6.
14. Farrant JM, Hayllar KM, Wilkinson ML et al. Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 1991; 100: 1710-17.
15. Escorsell A, Pares A, Rodes J et al. Epidemiology of primary sclerosing cholangitis in Spain. J. Hepatol. 1994; 21: 787-91.
16. Lindgren S, Nilsson S, Nassberger L et al. Anti-neutrophil cytoplasmic antibodies in patients with chronic liver diseases: Prevalence, antigen specificity and predictive value for diagnosis of autoimmune liver disease. Swedish Internal Medicine Liver Club. J. Gastroenterol. Hepatol. 2000; 15: 437-42.
17. Snook JA, Chapman RW, Fleming K, Jewell DP. Antineutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin. Exp. Immunol. 1989; 76: 30-3.
18. Seibold F, Weber P, Klein P et al. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis. Gut 1992; 33: 657-62.
19. Roozendaal C, van Milligan de Wit AWM, Haagsma EB et al. Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: Defined specificities may be associated with distinct clinical features. Am. J. Med. 1998; 105: 393-9.
20. Mulder AHL, Horst G, Haagsma EB et al. Antineutrophil cytoplasmic antibodies in autoimmune liver diseases. Hepatology 1993; 17: 411-17.
21. Hardarson S, LaBrecque DR, Mitros FA et al. Antineutrophil cytoplasmic antibody in inflammatory bowel and hepatobiliary diseases. Am. J. Clin. Pathol. 1993; 99: 277-81.
22. Angulo P, Peter JB, Gershwin ME et al. Serum autoantibodies in patients with primary sclerosing cholangitis. J. Hepatol. 2000; 32: 182-7.
23. Fausa O, Schrumpf E, Elgjo K. Relationship of inflammatory bowel disease and primary sclerosing cholangitis. Semin. Liver Dis. 1991; 11: 31-9.
24. Schrumpf E, Boberg KM. Epidemiology of primary sclerosing cholangitis. Best Pract. Res. Clin. Gastroenterol. 2001; 15: 553-62.
25. Duerr RH, Targan SR, Landers CJ et al. Neutrophil cytoplasmic antibodies: A link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1991; 100: 1385-91.
26. Bansi DS, Fleming KA, Chapman RW. Antineutrophil cytoplasmic antibodies in autoimmune hepatitis. Gastroenterology 1995; 109: 2049-55.
27. Wilschanski M, Chait P, Wade JA et al. Primary sclerosing cholangitis in 32 children: Clinical, laboratory and radiographic features, with survival analysis. Hepatology 1995; 22: 1415-22.
28. Porayko MK, Wiesner RH, LaRusso NF et al. Patients with primary sclerosing cholangitis frequently have progressive disease. Gastroenterology 1990; 98: 1594-602.
29. May GR, Bender CE, LaRusso NF, Wiesner RH. Non-operative dilatation of dominant strictures in primary sclerosing cholangitis. AJR 1985; 145: 1061-4.
30. Mitchell SA, Bansi DS, Hunt N et al. A preliminary trial of high dose ursodeoxycholic acid in primary sclerosing cholangitis. Gastroenterology 2001; 121: 900-7.